1. Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?

   • Mario Cazzola
   • Paola Rogliani
   • Maria Gabriella Matera

   Current Opinion Open access 12 June 2023 Pages: 957 - 965

   

2. Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review

   • Francesco Venuti
   • Mattia Trunfio
   • Andrea Calcagno

   Review Article 14 June 2023 Pages: 967 - 983

   

3. Focus on Metformin: Its Role and Safety in Pregnancy and Beyond

   • Christine Newman
   • Louise Rabbitt
   • Fidelma P. Dunne

   Review Article Open access 24 June 2023 Pages: 985 - 999

4. Neuropathic Pain and Spinal Cord Injury: Management, Phenotypes, and Biomarkers

   • Eva Widerström-Noga

   Review Article 16 June 2023 Pages: 1001 - 1025

   

5. Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis

   • Amalie Rehde
   • Sebastian Kjærgaard Hendel
   • Ole Haagen Nielsen

   Systematic Review 26 June 2023 Pages: 1027 - 1038

   

6. Tofersen: First Approval

   • Hannah A. Blair

   AdisInsight Report 15 June 2023 Pages: 1039 - 1043

   

7. Mirikizumab: First Approval

   • Susan J. Keam

   AdisInsight Report 30 June 2023 Pages: 1045 - 1052

   

8. Concizumab: First Approval

   • Susan J. Keam

   AdisInsight Report 21 June 2023 Pages: 1053 - 1059

   

9. Correction to: Lenacapavir: First Approval

   • Julia Paik

   Correction Open access 14 June 2023 Pages: 1061 - 1061

10. Correction to: Zavegepant: First Approval

    • Sohita Dhillon

    Correction Open access 27 June 2023 Pages: 1063 - 1063

11. Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’

    • Chia Siang Kow
    • Dinesh Sangarran Ramachandram
    • Syed Shahzad Hasan

    Correction 11 May 2023 Pages: 1065 - 1065